The effectiveness of three months EGFR-CTH therapy in palliative colorectal cancer
The EGFR-CTH protocol can be regarded as an effective palliative therapy for terminal colon and rectal cancer disease. The EGFR-CTH protocol contributes to 3.6 times higher probability of CT-proven tumor regression within three months of treatment. Large-volume studies are required to confirm the outcomes presented.
Authors
- Maciej Jankowski (ORCID: https://orcid.org/0000-0003-4540-6955)
- Tomasz Kamil Urbanowicz (ORCID: https://orcid.org/0000-0001-8080-2764)
- K. Bratos
Institutions
- Poznan University of Medical Sciences (PL)
- Greater Poland Cancer Center (PL)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2025-08-08
- DOI
- https://doi.org/10.5603/rpor.106280
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00